CompletedNot Applicable

Swalqol in Primary Hyperparathyroidism

Turkey (Türkiye)150 participantsStarted 2018-11-01

Plain-language summary

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * no diagnosis of Alzheimers disease * must be able to swallow tablets Planned operation for primary hyperparathyroidism Exclusion Criteria: * secondary or tertiary hyperparathyroidism * insulin dependent diabetes * thyroid disease

What they're measuring

Change in quality of life

Timeframe: 6 months

Trial details

NCT IDNCT03968510

SponsorUşak University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-07-01

View on ClinicalTrials.gov More Hyperparathyroidism trials